9992:HKEXPop Mart International Group Limited Analysis
Data as of 2026-07-28 - not real-time
HK$162.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Pop Mart is trading below its short‑term moving averages, indicating a bearish technical backdrop, while the MACD histogram remains positive and the RSI sits near the midpoint, suggesting limited downside momentum. Volume has been tapering, and the 30‑day volatility is elevated, which aligns with a market sentiment of extreme greed that could fuel a short‑term bounce.
Fundamentally, the company delivers exceptional profitability margins, a robust return on equity, and a very low dividend payout ratio, underscoring strong cash generation and dividend sustainability. The discounted cash‑flow model points to a substantial valuation gap, and analyst consensus remains bullish with a buy recommendation, making the stock appear significantly undervalued relative to its earnings and book value.
Fundamentally, the company delivers exceptional profitability margins, a robust return on equity, and a very low dividend payout ratio, underscoring strong cash generation and dividend sustainability. The discounted cash‑flow model points to a substantial valuation gap, and analyst consensus remains bullish with a buy recommendation, making the stock appear significantly undervalued relative to its earnings and book value.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term averages
- Positive MACD histogram but decreasing volume
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside versus DCF estimate
- Strong profit margins and cash flow generation
- Low payout ratio supporting dividend sustainability
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High return on equity and durable brand appeal
- Undervalued relative to earnings and book value
- Consistent analyst buy consensus and growth trajectory
Key Metrics & Analysis
Financial Health
Revenue Growth174.10%
Profit Margin34.42%
P/E Ratio14.7
ROE77.60%
ROA45.32%
Debt/Equity12.63
P/B Ratio8.4
Op. Cash FlowHK$10.9B
Free Cash FlowHK$9.1B
Technical Analysis
TrendBearish
RSI52.6
SupportHK$147.10
ResistanceHK$170.90
MA 20HK$157.83
MA 50HK$162.16
MA 200HK$195.13
MACDBullish
VolumeDecreasing
Fear & Greed Index87.7
Valuation
Fair ValueHK$253.68
Target PriceHK$213.94
Upside/Downside31.42%
GradeUndervalued
TypeGrowth
Dividend Yield1.65%
Risk Assessment
Beta0.69
Volatility35.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.